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Verzilli et al., 859
By utilizing the data produced by multiple independent-
association studies, meta-analyses can increase sample
size and the power to detect an association. Difﬁculties
arise when the studies being combined use different plat-
forms and/or genotype different markers. It is possible to
exclude data from SNPs that are not common among the
studies, but valuable information can be lost in this pro-
cess. Ideally, the combination of studies would include
imputing missing SNPs on the basis of LD relationships
with the markers that were typed. Verzilli et al. develop a
method that incorporates LD from databases or other
studies to generate data frommarkers across all studies. Ad-
ditionally, because raw data are not always provided from
the independent analyses, the method is able to utilize
summary data in its measurements. The authors use their
method to combine the data from different studies that
look at genetic associations between variants in the C-reac-
tive protein (CRP) region and levels of CRP in plasma. By
using all information, they are able to ﬁne map the region
and parse out independent effects of the analyzed SNPs.
Human Mitochondrial Substitution Rate
Endicott and Ho, 895
When studying evolutionary events such as selection, pop-
ulationmigrations, and population expansions, researchers
make timing estimates on the basis of genetic data. A great
deal of such work has been done via analysis of mitochon-
drial DNA (mtDNA), but accurately dating events with
mtDNArequires a trustworthymeasurementofmtDNAsub-
stitution rates. If the substitution rate is underestimated, the
timescale to a historicalmomentwill be inﬂated; likewise, if
the substitution rate is too high, history will be condensed.
Methods of determining the rates for different regions of
mtDNA have been proposed, but there hasn’t been a stan-
dardized way to establish the substitution rates across the
mtDNA. Endicott and Ho developed a Bayesian model-
based approach to do just that. Using the new method,
the authors assess the importance of calibration in the rate
estimations. They ﬁnd that using an external human-chim-
panzee source yields greatly different results than using an
internal calibration based on known historical time points.
Because the estimation of substitution rate is lower when
one uses the external calibration, the corresponding time1Deputy Editor, AJHG
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Theto the most recent ancestor is higher. The internally cali-
brated estimates of substitution rates are higher than those
previously reported, meaning that divergence times are de-
termined to bemore recent than previously thought. These
new times correlate well with archaeological evidence.
SNP Arrays in Heterogeneous Tissue Samples
Assie et al., 903
Because of the importance of determining the genetic dif-
ferences between normal tissue and cancer cells, methods
of comparing germline and somatic genotypes have been
developed. Genome-wide methods utilizing data from
SNP arrays have been implemented, but current analyses
can be limited by the need to have matched normal sam-
ples for each tumor sample, aswell as by the contamination
of normal cells mixed into tumor samples. Assie et al.
introduce SOMATICs, which uses the normal cells within
a tumor sample as an internal control. By taking advantage
of tissue heterogeneity, SOMATICs is able not only to over-
come several of the problems faced by other methods but
also to detect genetic aberrations with increased sensitivity.
When applied to 54 samples, SOMATICs identiﬁes small
genetic alterations that occur in a small number of cells.
The method can also differentiate germline changes from
somatic changes and delineate the boundaries of the
alterations. Importantly, SOMATICs can also estimate the
proportion of affected cells in a sample along with a signi-
ﬁcance value for this measurement. This determination of
tumor content is important for diagnostic predictions but
is difﬁcult to determine through other means.
Small RNAs Mapping in Encode Regions
Borel et al., 971
The human genome has been sequenced, but researchers
are still trying to ﬁgure out what all that sequence does. In-
creasing evidence suggests that a large number of genomic
regions are transcribed, but for the most part not in the
traditional gene (ie. coding) sense. The importance of
noncoding RNAs has been recognized in work including
studies of antisense RNAs and microRNAs. Variants in
the regions generating such RNAs are also being evaluated
for their involvement in increasing disease risk or in con-
tributing to other phenotypic characteristics. If one wishes
to better understand what all these RNAs do, it is useful toGenetics. All rights reserved.
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ﬁrst establish what and where all the RNAs are. Studies
have cataloged long RNAs and, here, Borel et al. compre-
hensively analyze the small RNAs, 19–50 nucleotides in
length, that are generated from within the 44 ENCODE
regions. An interesting correlation is noted between an
increase in the small RNAs near the transcription start
site of genes and higher gene expression. This ﬁnding is
in line with a previously reported observation that an
increase in aborted transcripts is related to an increase in
gene expression. Additionally, a high proportion of sense/
anti-sense RNA pairs are identiﬁed, thereby contributing
data to the growing evidence of extensive antisense tran-
scription in the genome.
Identification of the SPG15 Gene
Hanein et al., 992
Hereditary spastic paraplegia (HSP) can be uncomplicated
or accompanied by other features, ranging from mental806 The American Journal of Human Genetics 82, 805–806, April 20retardation and deafness to epilepsy and retinitis pigmen-
tosa. A locus for SPG15, a complicated and autosomal-
recessive (AR) form of the disease, was recently mapped
to 14q22-q24 in two Irish families. Of the 16 known
loci for complicated AR-HSP, SPG15 was predicted to ac-
count for 15% of AR-HSP cases. Hanein et al. study eight
SPG15 families to further reﬁne the locus and determine
which gene is disrupted in this form of AR-HSP. In a ﬁrst
round of screening, three candidate genes in the region
are chosen on the basis of their involvement with intra-
cellular trafﬁcking or mitochondrial function, but no
disease-causing variants are found. The sequence of
ZFYVE26 is then analyzed because other genes in the
same family have been found to be disrupted in related
diseases. Truncation mutations in ZFYVE26 are identiﬁed
in each of the families. Expression work reveals that the
gene is widely expressed and that the localization of
the gene product suggests a potential role in endosomal
trafﬁcking.08
